LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 0.37 | uM | LJP5 | 2 | N16 | 72 | hr | 2543 | 6188 | 5578 | 1.1092 | 1.2008 |
| SK-BR-3 | Nilotinib | 0.37 | uM | LJP5 | 3 | N16 | 72 | hr | 2543 | 6413 | 5578 | 1.1496 | 1.2749 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 2543 | 5386 | 5578 | 0.9655 | 0.9365 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 2543 | 4910 | 5578 | 0.8801 | 0.7797 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 2543 | 5398 | 5578 | 0.9676 | 0.9405 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 1 | C10 | 72 | hr | 2543 | 5009 | 5578 | 0.8979 | 0.8123 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 2 | C10 | 72 | hr | 2543 | 5324 | 5578 | 0.9544 | 0.9161 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 3 | C10 | 72 | hr | 2543 | 5364 | 5578 | 0.9615 | 0.9293 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 1 | M16 | 72 | hr | 2543 | 1926 | 5578 | 0.3452 | -0.2034 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 2 | M16 | 72 | hr | 2543 | 1946 | 5578 | 0.3488 | -0.1968 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 3 | M16 | 72 | hr | 2543 | 2255 | 5578 | 0.4042 | -0.0950 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 1 | K16 | 72 | hr | 2543 | 5288 | 5578 | 0.9479 | 0.9042 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 2 | K16 | 72 | hr | 2543 | 5305 | 5578 | 0.9509 | 0.9098 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 3 | K16 | 72 | hr | 2543 | 5656 | 5578 | 1.0139 | 1.0255 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 2543 | 4423 | 5578 | 0.7928 | 0.6193 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 2543 | 4135 | 5578 | 0.7412 | 0.5244 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 2543 | 4171 | 5578 | 0.7477 | 0.5362 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 1 | C04 | 72 | hr | 2543 | 5243 | 5578 | 0.9398 | 0.8894 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 2 | C04 | 72 | hr | 2543 | 5191 | 5578 | 0.9305 | 0.8723 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 3 | C04 | 72 | hr | 2543 | 5475 | 5578 | 0.9814 | 0.9659 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 1 | E04 | 72 | hr | 2543 | 5409 | 5578 | 0.9696 | 0.9441 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 2 | E04 | 72 | hr | 2543 | 4947 | 5578 | 0.8868 | 0.7919 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 3 | E04 | 72 | hr | 2543 | 5359 | 5578 | 0.9606 | 0.9276 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 2543 | 5339 | 5578 | 0.9570 | 0.9210 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 2543 | 5523 | 5578 | 0.9900 | 0.9817 |